Our application for the Horizon Europe project “PREDISPOSE” has been approved. The project starts on 1 March 2027 and is funded by the European Union for five years with about €8.1 million. The Babel Lab takes part as partner for Ruhr University Bochum.
PREDISPOSE (Predicting Susceptibility and Defining Endotypes for Precision Interventions in Long COVID) uses Long COVID as a model to study why some people develop long-term illness after an infection. The project aims to divide Long COVID into endotypes, to validate biomarkers for a point-of-care diagnostic, and to test new treatments, among them non-invasive vagus nerve stimulation.
The consortium is coordinated by IrsiCaixa in Barcelona and brings together eleven partners from seven European countries, including the patient organisation Long Covid Europe. We look forward to the collaboration and will report here when the project starts.
Image by Freepik
